Estrogen and ischemic heart disease in females

Introduction: Although ischemic heart disease (IHD) develops in both genders under the influence of the same risk factors, it is much less frequent among female population, which is mostly assigned to favorable effects of estrogen. Objective: Since latest investigations have pointed to higher incide...

Full description

Bibliographic Details
Main Authors: Stević-Gajić Vesna, Borzanović Milorad, Obrenović Radmila, Nikolić Jelenka, Lepopojić Olgica, Đinđić Ljubica
Format: Article
Language:English
Published: Serbian Medical Society 2006-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0370-8179/2006/0370-81790610393S.pdf
id doaj-d241cd5cb1eb4013ad68254a27b71246
record_format Article
spelling doaj-d241cd5cb1eb4013ad68254a27b712462021-01-02T02:42:50ZengSerbian Medical SocietySrpski Arhiv za Celokupno Lekarstvo0370-81792006-01-011349-1039339710.2298/SARH0610393SEstrogen and ischemic heart disease in femalesStević-Gajić VesnaBorzanović MiloradObrenović RadmilaNikolić JelenkaLepopojić OlgicaĐinđić LjubicaIntroduction: Although ischemic heart disease (IHD) develops in both genders under the influence of the same risk factors, it is much less frequent among female population, which is mostly assigned to favorable effects of estrogen. Objective: Since latest investigations have pointed to higher incidence of disease in female population, the objective of our study was to examine the relation between estrogen and other clinical and biochemical parameters significant for its manifestation. Method: The relation between estrogen levels and frequency of obesity, diabetes, hypertension as well as the levels of total, HDL, LDL i VLDL cholesterol, triglycerides, Lp(a), apoprotein A i B i PAI-1 was analyzed in 50 (25 pre- and postmenopausal) patients, treated due to IHD in the Health Center, Krusevac, in 2002 year. Results: Low concentration of estrogen was found in 22 (44%) patients. In addition, frequency of diabetes, obesity and risky levels of high atherogenic lipid fractions (total and LDL cholesterol, Lp(a), apoprotein B) was insignificantly higher, whereas the concentrations of PAI 1, triglycerides and HDL cholesterol were lower, with significant correlation between estrogen level and PAI-1 (T=0.32, p<0.05). Conclusion: Despite all past investigations, numerous questions related to high incidence of IHD among premenopausal women, have remained open - whether it occurs as a consequence of reduced estrogen synthesis, lower expression of estrogen receptors, their modified function or maybe concomitant influence of other risk factors, not necessarily connected with sex, that eliminate protective effects of this hormone. http://www.doiserbia.nb.rs/img/doi/0370-8179/2006/0370-81790610393S.pdfischemic heart diseasefemalesestrogen
collection DOAJ
language English
format Article
sources DOAJ
author Stević-Gajić Vesna
Borzanović Milorad
Obrenović Radmila
Nikolić Jelenka
Lepopojić Olgica
Đinđić Ljubica
spellingShingle Stević-Gajić Vesna
Borzanović Milorad
Obrenović Radmila
Nikolić Jelenka
Lepopojić Olgica
Đinđić Ljubica
Estrogen and ischemic heart disease in females
Srpski Arhiv za Celokupno Lekarstvo
ischemic heart disease
females
estrogen
author_facet Stević-Gajić Vesna
Borzanović Milorad
Obrenović Radmila
Nikolić Jelenka
Lepopojić Olgica
Đinđić Ljubica
author_sort Stević-Gajić Vesna
title Estrogen and ischemic heart disease in females
title_short Estrogen and ischemic heart disease in females
title_full Estrogen and ischemic heart disease in females
title_fullStr Estrogen and ischemic heart disease in females
title_full_unstemmed Estrogen and ischemic heart disease in females
title_sort estrogen and ischemic heart disease in females
publisher Serbian Medical Society
series Srpski Arhiv za Celokupno Lekarstvo
issn 0370-8179
publishDate 2006-01-01
description Introduction: Although ischemic heart disease (IHD) develops in both genders under the influence of the same risk factors, it is much less frequent among female population, which is mostly assigned to favorable effects of estrogen. Objective: Since latest investigations have pointed to higher incidence of disease in female population, the objective of our study was to examine the relation between estrogen and other clinical and biochemical parameters significant for its manifestation. Method: The relation between estrogen levels and frequency of obesity, diabetes, hypertension as well as the levels of total, HDL, LDL i VLDL cholesterol, triglycerides, Lp(a), apoprotein A i B i PAI-1 was analyzed in 50 (25 pre- and postmenopausal) patients, treated due to IHD in the Health Center, Krusevac, in 2002 year. Results: Low concentration of estrogen was found in 22 (44%) patients. In addition, frequency of diabetes, obesity and risky levels of high atherogenic lipid fractions (total and LDL cholesterol, Lp(a), apoprotein B) was insignificantly higher, whereas the concentrations of PAI 1, triglycerides and HDL cholesterol were lower, with significant correlation between estrogen level and PAI-1 (T=0.32, p<0.05). Conclusion: Despite all past investigations, numerous questions related to high incidence of IHD among premenopausal women, have remained open - whether it occurs as a consequence of reduced estrogen synthesis, lower expression of estrogen receptors, their modified function or maybe concomitant influence of other risk factors, not necessarily connected with sex, that eliminate protective effects of this hormone.
topic ischemic heart disease
females
estrogen
url http://www.doiserbia.nb.rs/img/doi/0370-8179/2006/0370-81790610393S.pdf
work_keys_str_mv AT stevicgajicvesna estrogenandischemicheartdiseaseinfemales
AT borzanovicmilorad estrogenandischemicheartdiseaseinfemales
AT obrenovicradmila estrogenandischemicheartdiseaseinfemales
AT nikolicjelenka estrogenandischemicheartdiseaseinfemales
AT lepopojicolgica estrogenandischemicheartdiseaseinfemales
AT đinđicljubica estrogenandischemicheartdiseaseinfemales
_version_ 1724361725327704064